Á lódáil...
Overcoming stroma-mediated treatment resistance in chronic lymphocytic leukemia through BCL-2 inhibition
Despite recent advances in the treatment of chronic lymphocytic leukemia (CLL) with chemoimmunotherapy, many CLL patients are older or frail and cannot tolerate aggressive chemotherapy. Even those who can inevitably develop resistance due to factors such as deletion of pro-apoptotic factors like TP5...
Na minha lista:
| Foilsithe in: | Leuk Lymphoma |
|---|---|
| Main Authors: | , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
2013
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4557771/ https://ncbi.nlm.nih.gov/pubmed/23614795 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2013.796051 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|